NCT01857063View on ClinicalTrials.gov

Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 10, 2013

Primary Completion Date

September 1, 2013

Study Completion Date

September 1, 2013

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Montelukast

Montelukast 5 mg chewable tablets, taken orally once daily at bedtime for 7 days

DRUG

Placebo

Matching placebo chewable tablets, taken orally once daily at bedtime for 7 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01857063 - Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519) | Biotech Hunter | Biotech Hunter